Immune thrombocytopenic purpura (ITP) is a rare but serious complication that happens in an estimated 1-5% of those living with CLL and SLL.

Measurable residual disease (MRD) testing measures the amount of cancer cells that are present in blood or bone marrow at the time the sample was collected.

MBL is a condition where there is an accumulation of abnormal B-cells in the blood.

A one page summary of what you need to know about the 3 most important tests that need to be done to guide your CLL treatment.

Fatigue is one of the most common symptoms experienced by those living with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), and it is also commonly overlooked, underreported, and undertreated.

Targeted oral treatment options for CLL and SLL are medications taken by mouth that identify and attack specific cancer cells.

A variety of tests are used to capture images inside the body when chronic lymphocytic leukemia (CLL) and small
lymphocytic lymphoma (SLL) are present. Imaging tests are used to look inside the body to capture pictures that will help the healthcare team visualize what, if any, internal changes might be occurring.